ESN364
2693-CL-0020
Phase 1 small_molecule completed
Quick answer
ESN364 for Healthy Subjects is a Phase 1 program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma Inc
- Indication
- Healthy Subjects
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed